Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new Oxford-led study highlights the potential of a molecular imaging agent used alongside non-invasive scanning to improve the diagnosis and monitoring of endometriosis - a condition affecting an estimated 190 million women worldwide where delayed diagnosis remains a significant women's health challenge.

A Phase II Study, published in The Lancet Obstetrics, Gynaecology & Women's Health, highlights the potential of a new molecular imaging agent, ‘99mTc-maraciclatide’, when used alongside a non-invasive scan to diagnose and monitor the development and treatment of Endometriosis.

The study, “Detecting Endometriosis Expressed Integrins using Technetium-99m (DETECT)”, is a collaboration between clinical radiopharmaceutical company, Serac Healthcare Ltd and the Nuffield Department of Women’s & Reproductive Health.

About the study

The study evaluated 19 individuals with suspected or confirmed pelvic or thoracic endometriosis. Participants underwent preoperative SPECT-CT imaging, a non-invasive scan, following intravenous administration of 99mTc-maraciclatide.

This imaging agent binds to αvβ3 integrins, which are upregulated during angiogenesis (the formation of new blood vessels), a key feature of inflammatory diseases such as endometriosis. By visualising this process, the scan can detect areas of disease.

The study found that this non-invasive approach performed comparably to laparoscopic surgery in detecting endometriosis. 

Read the full story on the Nuffield Department of Women's & Reproductive Health website.

 

 

 

Similar stories

From Responsive to Deep Solidarity: Reframing Global Health Governance in an Interdependent World

A new paper co-authored by Oxford Global Health Co-Director Professor Caesar Atuire and Athanasius Afful from the University of Ghana explores how the concepts of deep solidarity and responsive solidarity can help reframe global health governance and address persistent inequities.

Inside the Medicine Quality Monitoring Globe: tracking medicine quality risks in real time

A new study sets the development and the process powering the Medicine Quality Monitoring Globe, the interactive, online tool that maps real-time medicine quality reports in the media. As of October 2026, the system has captured 2.5 million articles.

Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma in Tanzania

New research has found that adding rituximab to chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma in Tanzania.

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

Oxford researchers support international response to Bundibugyo virus disease outbreak

Teams from across the University of Oxford are supporting the international response to the current Bundibugyo virus disease outbreak through interdisciplinary research spanning biomedical, public health and social and behavioural science.

Smoking and drinking exacerbate social inequalities in premature deaths in India

Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.

Similar stories

From Responsive to Deep Solidarity: Reframing Global Health Governance in an Interdependent World

A new paper co-authored by Oxford Global Health Co-Director Professor Caesar Atuire and Athanasius Afful from the University of Ghana explores how the concepts of deep solidarity and responsive solidarity can help reframe global health governance and address persistent inequities.

Inside the Medicine Quality Monitoring Globe: tracking medicine quality risks in real time

A new study sets the development and the process powering the Medicine Quality Monitoring Globe, the interactive, online tool that maps real-time medicine quality reports in the media. As of October 2026, the system has captured 2.5 million articles.

Adding rituximab to chemotherapy is a cost-effective treatment for Burkitt lymphoma in Tanzania

New research has found that adding rituximab to chemotherapy could be a cost-effective way to improve survival in children with Burkitt lymphoma in Tanzania.

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

Oxford researchers support international response to Bundibugyo virus disease outbreak

Teams from across the University of Oxford are supporting the international response to the current Bundibugyo virus disease outbreak through interdisciplinary research spanning biomedical, public health and social and behavioural science.

Smoking and drinking exacerbate social inequalities in premature deaths in India

Study finds social inequality is a major predictor of premature death, even among people who neither smoke nor drink alcohol.